Variability in erythrocyte fructosamine 3-kinase activity in humans correlates with polymorphisms in the FN3K gene and impacts on haemoglobin glycation at specific sites.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 16523184)

Published in Diabetes Metab on February 01, 2006

Authors

G Delpierre1, M Veiga-da-Cunha, D Vertommen, M Buysschaert, E Van Schaftingen

Author Affiliations

1: Laboratory of Physiological Chemistry, ICP and Université catholique de Louvain, Brussels, Belgium.

Articles by these authors

A kinetic study of pyrophosphate: fructose-6-phosphate phosphotransferase from potato tubers. Application to a microassay of fructose 2,6-bisphosphate. Eur J Biochem (1982) 6.74

Fructose 2,6-bisphosphate 2 years after its discovery. Biochem J (1982) 2.91

Control of the fructose-6-phosphate/fructose 1,6-bisphosphate cycle in isolated hepatocytes by glucose and glucagon. Role of a low-molecular-weight stimulator of phosphofructokinase. Biochem J (1980) 2.88

Fructose 2,6-bisphosphate, the probably structure of the glucose- and glucagon-sensitive stimulator of phosphofructokinase. Biochem J (1980) 2.79

Inhibition of fructose-1,6-bisphosphatase by fructose 2,6-biphosphate. Proc Natl Acad Sci U S A (1981) 2.44

Phosphorylation and activation of heart 6-phosphofructo-2-kinase by protein kinase B and other protein kinases of the insulin signaling cascades. J Biol Chem (1997) 2.43

Mutations in PMM2, a phosphomannomutase gene on chromosome 16p13, in carbohydrate-deficient glycoprotein type I syndrome (Jaeken syndrome). Nat Genet (1997) 2.30

A new class of phosphotransferases phosphorylated on an aspartate residue in an amino-terminal DXDX(T/V) motif. J Biol Chem (1998) 2.29

L-2-hydroxyglutaric aciduria, a defect of metabolite repair. J Inherit Metab Dis (2007) 2.02

A CCAAT DNA binding factor consisting of two different components that are both required for DNA binding. J Biol Chem (1988) 1.93

Control of liver 6-phosphofructokinase by fructose 2,6-bisphosphate and other effectors. Proc Natl Acad Sci U S A (1981) 1.91

Sequence of a putative glucose 6-phosphate translocase, mutated in glycogen storage disease type Ib. FEBS Lett (1997) 1.86

Fructose 2,6-bisphosphate. Adv Enzymol Relat Areas Mol Biol (1987) 1.71

Study of the fructose 6-phosphate/fructose 1,6-bi-phosphate cycle in the liver in vivo. Biochem J (1980) 1.69

Lack of homozygotes for the most frequent disease allele in carbohydrate-deficient glycoprotein syndrome type 1A. Am J Hum Genet (1998) 1.66

Hormonal control of fructose 2,6-bisphosphate concentration in isolated rat hepatocytes. Biochem J (1983) 1.64

Cushing syndrome and medroxyprogesterone acetate. Lancet (1990) 1.60

Phosphofructokinase 2: the enzyme that forms fructose 2,6-bisphosphate from fructose 6-phosphate and ATP. Biochem Biophys Res Commun (1981) 1.58

Hyperglycaemic effect of nifedipine. Br Med J (Clin Res Ed) (1981) 1.50

3-Phosphoglycerate dehydrogenase deficiency: an inborn error of serine biosynthesis. Arch Dis Child (1996) 1.45

Effectors of the regulatory protein acting on liver glucokinase: a kinetic investigation. Eur J Biochem (1991) 1.44

Pathway and regulation of erythritol formation in Leuconostoc oenos. J Bacteriol (1993) 1.43

The mechanism by which rat liver glucokinase is inhibited by the regulatory protein. Eur J Biochem (1990) 1.43

The putative glucose 6-phosphate translocase gene is mutated in essentially all cases of glycogen storage disease type I non-a. Eur J Hum Genet (1999) 1.42

L: -2-Hydroxyglutaric aciduria, a disorder of metabolite repair. J Inherit Metab Dis (2008) 1.40

[Is there a link between secondary hemochromatosis and genetics? Apropos of 2 cases]. Acta Clin Belg (1999) 1.39

Heterogeneity in glucose sensitivity among pancreatic beta-cells is correlated to differences in glucose phosphorylation rather than glucose transport. EMBO J (1993) 1.34

Identification, cloning, and heterologous expression of a mammalian fructosamine-3-kinase. Diabetes (2000) 1.34

Formation of fructose 2,6-bisphosphate from fructose 1,6-bisphosphate by intramolecular cyclisation followed by alkaline hydrolysis. Eur J Biochem (1981) 1.31

Species and tissue distribution of the regulatory protein of glucokinase. Biochem J (1993) 1.30

The glucose sensor protein glucokinase is expressed in glucagon-producing alpha-cells. Proc Natl Acad Sci U S A (1996) 1.28

A gene on chromosome 11q23 coding for a putative glucose- 6-phosphate translocase is mutated in glycogen-storage disease types Ib and Ic. Am J Hum Genet (1998) 1.28

The stimulation of yeast phosphofructokinase by fructose 2,6-bisphosphate. FEBS Lett (1982) 1.27

Synthesis of a stimulator of phosphofructokinase, most likely fructose 2,6-bisphosphate, from phosphoric acid and fructose 6-phosphoric acid. Biochem Biophys Res Commun (1980) 1.26

Mutations in the glucokinase regulatory protein gene in 2p23 in obese French caucasians. Diabetologia (2003) 1.21

Phosphomannose isomerase deficiency: a carbohydrate-deficient glycoprotein syndrome with hepatic-intestinal presentation. Am J Hum Genet (1998) 1.20

RNAi screening in glioma stem-like cells identifies PFKFB4 as a key molecule important for cancer cell survival. Oncogene (2011) 1.20

Mechanistic studies of phosphoserine phosphatase, an enzyme related to P-type ATPases. J Biol Chem (1999) 1.17

Competitive inhibition of liver glucokinase by its regulatory protein. Eur J Biochem (1991) 1.16

Regulation of glucokinase by a fructose-1-phosphate-sensitive protein in pancreatic islets. Eur J Biochem (1990) 1.15

Fructose 1-phosphate and the regulation of glucokinase activity in isolated hepatocytes. Eur J Biochem (1990) 1.12

Inactivation of phosphofructokinase 2 by cyclic AMP - dependent protein kinase. Biochem Biophys Res Commun (1981) 1.12

Human L-3-phosphoserine phosphatase: sequence, expression and evidence for a phosphoenzyme intermediate. FEBS Lett (1997) 1.12

On the mechanism of inhibition of neutral liver fructose 1,6-bisphosphatase by fructose 2,6-bisphosphate. Eur J Biochem (1983) 1.11

The ability of adenosine to decrease the concentration of fructose 2,6-bisphosphate in isolated hepatocytes. A cyclic AMP-mediated effect. Biochem J (1984) 1.09

Kinetic properties and tissular distribution of mammalian phosphomannomutase isozymes. Biochem J (1999) 1.08

The mechanism by which glucose increases fructose 2,6-bisphosphate concentration in Saccharomyces cerevisiae. A cyclic-AMP-dependent activation of phosphofructokinase 2. Eur J Biochem (1984) 1.07

Effects of glucose and glucagon on the fructose 2,6-bisphosphate content of pancreatic islets and purified pancreatic B-cells. A comparison with isolated hepatocytes. Biochem J (1984) 1.07

High residual activity of PMM2 in patients' fibroblasts: possible pitfall in the diagnosis of CDG-Ia (phosphomannomutase deficiency). Am J Hum Genet (2001) 1.06

Purification and properties of phosphofructokinase 2/fructose 2,6-bisphosphatase from chicken liver and from pigeon muscle. Eur J Biochem (1986) 1.06

acs1 of Haemophilus influenzae type a capsulation locus region II encodes a bifunctional ribulose 5-phosphate reductase- CDP-ribitol pyrophosphorylase. J Bacteriol (1999) 1.06

The regulatory protein of glucokinase. Biochem Soc Trans (1997) 1.06

The gene mutated in l-2-hydroxyglutaric aciduria encodes l-2-hydroxyglutarate dehydrogenase. Biochimie (2005) 1.06

Amino acid conservation in animal glucokinases. Identification of residues implicated in the interaction with the regulatory protein. J Biol Chem (1996) 1.06

Effects of various metabolic conditions and of the trivalent arsenical melarsen oxide on the intracellular levels of fructose 2,6-bisphosphate and of glycolytic intermediates in Trypanosoma brucei. Eur J Biochem (1987) 1.05

Interference by pyruvate carboxylase in the measurement of acetyl-CoA carboxylase in crude liver preparations. Biochem J (1982) 1.05

[Palpebral asymmetry and Graves' ophthalmopathy]. Acta Neurol Belg (1988) 1.05

Identification of the cDNA encoding human 6-phosphogluconolactonase, the enzyme catalyzing the second step of the pentose phosphate pathway(1). FEBS Lett (1999) 1.04

Gastric acid and pancreatic polypeptide responses to sham feeding are impaired in diabetic subjects with autonomic neuropathy. Diabetes (1985) 1.04

Purification and properties of spinach leaf phosphofructokinase 2/fructose 2,6-bisphosphatase. Eur J Biochem (1986) 1.04

Comparison of PMM1 with the phosphomannomutases expressed in rat liver and in human cells. FEBS Lett (1997) 1.03

Stimulation of glycolysis and accumulation of a stimulator of phosphofructokinase in hepatocytes incubated with vasopressin. Biochem J (1981) 1.02

Prevalence of thyroid cancer in Graves' disease: a retrospective study of a cohort of 103 patients treated surgically. Eur J Intern Med (2003) 1.02

Glucose-6-phosphatase mutation G188R confers an atypical glycogen storage disease type 1b phenotype. Pediatr Res (2000) 1.01

Presence of a fructose-2,6-bisphosphate-insensitive pyrophosphate: fructose-6-phosphate phosphotransferase in the anaerobic protozoa Tritrichomonas foetus, Trichomonas vaginalis and Isotricha prostoma. Mol Biochem Parasitol (1989) 1.01

Binding of sorbitol 6-phosphate and of fructose 1-phosphate to the regulatory protein of liver glucokinase. Biochem J (1992) 1.01

Effect of mutations on the sensitivity of human beta-cell glucokinase to liver regulatory protein. Diabetologia (1996) 1.01

Phosphomannomutase deficiency is the main cause of carbohydrate-deficient glycoprotein syndrome with type I isoelectrofocusing pattern of serum sialotransferrins. J Inherit Metab Dis (1997) 0.99

PMM (PMM1), the human homologue of SEC53 or yeast phosphomannomutase, is localized on chromosome 22q13. Genomics (1997) 0.99

New targets of AMP-activated protein kinase. Biochem Soc Trans (2003) 0.98

Glucokinase regulatory protein is essential for the proper subcellular localisation of liver glucokinase. FEBS Lett (1999) 0.98

Cloning and expression of a Xenopus liver cDNA encoding a fructose-phosphate-insensitive regulatory protein of glucokinase. Eur J Biochem (1994) 0.97

Effect of benzoate on the metabolism of fructose 2,6-bisphosphate in yeast. Eur J Biochem (1986) 0.97

Phosphoserine phosphatase deficiency in a patient with Williams syndrome. J Med Genet (1997) 0.97

Study of the regulatory properties of glucokinase by site-directed mutagenesis: conversion of glucokinase to an enzyme with high affinity for glucose. Diabetes (2000) 0.96

The regulatory protein of glucokinase binds to the hepatocyte matrix, but, unlike glucokinase, does not translocate during substrate stimulation. Biochem J (1995) 0.96

Beneficial effects of L-serine and glycine in the management of seizures in 3-phosphoglycerate dehydrogenase deficiency. Ann Neurol (1998) 0.95

Molecular forms of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase expressed in rat skeletal muscle. J Biol Chem (1992) 0.94

3-phosphoglycerate dehydrogenase deficiency in a patient with West syndrome. Dev Med Child Neurol (2000) 0.94

The stimulation of phosphofructokinase from human erythrocytes by fructose 2,6-bisphosphate. FEBS Lett (1982) 0.93

The mechanism by which ethanol decreases the concentration of fructose 2,6-bisphosphate in the liver. Biochem J (1984) 0.92

Carbohydrate-deficient glycoprotein syndrome type IA (phosphomannomutase-deficiency). Biochim Biophys Acta (1999) 0.92

Serum lipoprotein(a) in patients with diabetes mellitus. Diabetes Care (1993) 0.92

[Hantavirus nephropathy in Belgium: description of 2 new cases originating in southern provinces]. Acta Clin Belg (1987) 0.92

Differential effects of glucose and fructose on liver L-type pyruvate kinase gene expression in vivo. J Biol Chem (1987) 0.92

Fructose 2,6-bisphosphate in yeast. Biochem Biophys Res Commun (1981) 0.91

Effect of ethylene treatment on the concentration of fructose-2,6-bisphosphate and on the activity of phosphofructokinase 2/fructose-2,6-bisphosphatase in banana. Eur J Biochem (1987) 0.91

Pancreas transplantation for treatment of generalized allergy to human insulin in type 1 diabetes. Transplant Proc (2005) 0.89

Rat muscle 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase. Study of the kinase domain by site-directed mutagenesis. J Biol Chem (1993) 0.89

Bone density and markers of bone remodeling in type 1 male diabetic patients. Diabetes Metab (2006) 0.89

Structure of the gene mutated in glycogen storage disease type Ib. Gene (1999) 0.89